Actinium presents breast cancer data for ATNM-400 at medical conference
Go back to Actinium presents breast cancer data for ATNM-400 at medical conference| Actinium Pharmaceuticals, Inc. (NYSE: ATNM) | Delayed: 1.05 +0.05 (5.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $3.50 | |||
| Open | $1.02 | 52 Week Low | $0.86 | |||
| Day High | $1.06 | P/E | N/A | |||
| Day Low | $1.01 | EPS | $-7.61 | |||
| Volume | 72,037 | |||||
